Centene Corporation $CNC Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC lowered its position in Centene Corporation (NYSE:CNC) by 4.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,618,417 shares of the company’s stock after selling 76,832 shares during the period. Centene makes up about 1.1% of Thompson Siegel & Walmsley LLC’s investment portfolio, making the stock its 20th biggest position. Thompson Siegel & Walmsley LLC owned approximately 0.33% of Centene worth $66,598,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Rothschild Wealth LLC acquired a new stake in Centene during the 4th quarter valued at $794,000. Waterloo Capital L.P. purchased a new position in shares of Centene in the 4th quarter worth $251,000. Nomura Asset Management Co. Ltd. raised its position in shares of Centene by 3.4% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 191,061 shares of the company’s stock worth $7,862,000 after buying an additional 6,348 shares during the period. Essex Financial Services Inc. purchased a new position in Centene in the fourth quarter valued at about $455,000. Finally, MUFG Securities EMEA plc raised its position in Centene by 114.4% in the fourth quarter. MUFG Securities EMEA plc now owns 19,149 shares of the company’s stock valued at $788,000 after purchasing an additional 10,218 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Zacks Research raised Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 6th. UBS Group reaffirmed a “neutral” rating and set a $61.00 target price (up from $55.00) on shares of Centene in a research report on Friday, May 22nd. Wells Fargo & Company lifted their target price on Centene from $44.00 to $56.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. TD Cowen reaffirmed a “hold” rating and set a $47.00 target price (up from $38.00) on shares of Centene in a research report on Monday, May 4th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $58.18.

Centene Stock Performance

Shares of NYSE CNC opened at $59.72 on Monday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. The stock has a 50 day simple moving average of $45.44 and a 200-day simple moving average of $42.47. The company has a market cap of $29.49 billion, a PE ratio of -4.54, a P/E/G ratio of 0.47 and a beta of 1.09. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $60.76.

Centene (NYSE:CNC) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $1.14. The business had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.53 billion. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The business’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.90 earnings per share. On average, equities research analysts forecast that Centene Corporation will post 3.45 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.